Latest News

Kamada Reports Financial Results for Third Quarter and First Nine Months of 2018

Nov. 12, 2018

Kamadad announced today financial results for the three and nine months ended September 30, 2018.

Kamada Announces Appointment of Life Sciences Industry Executive Eitan Kyiet as Vice President of Business Development

Oct. 24, 2018

Kamada announced today the appointment of Eitan Kyiet as Vice President of Business Development. Mr. Kyiet has over 20 years of experience in business development, strategic operations and corporate law, with a significant portion of his career spent in the life sciences industry. He will lead Kamada's business development and strategic commercial activities, with a focus on advancing market opportunities for the Company's products. Mr. Kyiet will report directly to Amir London, Kamada’s Chief Executive Officer.

Upcoming Events

Kamada to participate in European Society for Organ Transplantation

Nov. 6-10, 2018 / Munich, Germany

Moving forward from the past two successful editions of the ESOT “Bundled Meetings” (Budapest 2014 and Barcelona 2016) the TLJ2018 will serve as a new platform for speakers and participants to engage in a variety of presentations, dynamic discussions, networking opportunities, to lead a new paradigm in the field of transplantation.

Under the theme of “Transplantation Learning Journey”, a variety of targeted programs, one for each specialty, have been designed to cover the educational needs of all fields in healthcare and research with an affiliation in transplantation. 

Kamada to participate in Jefferies 2018 London Healthcare Conference

Nov. 14-15, 2018 / London, UK

The  event will feature leading public and private companies from the pharmaceuticals, biotechnology, generics, consumer health, animal health, medical technology and healthcare services sectors from the United States, Europe, Africa, Middle East, Latin America, Russia, India, Israel, China and Japan.

The two-day event will include concurrent tracks of company presentations, thematic panel discussions, and 1x1/small-group meetings. This global gathering of leading healthcare executives and institutional, private equity and venture capital investors will address near- and long-term investment opportunities and discuss the mechanisms driving global healthcare.

Past Event


Oct. 28 - Nov. 1, 2018 / Buenos Aires, Argentina

RITA is an international scientific meeting that has been held annually since 1990, the focus of which is the presentation and discussion of developments in rabies research, surveillance, control and prevention. Conference participants include researchers, academics, regulators, students, and medical, public health, and veterinary professionals, among others. The RITA conference provides unparalleled opportunities for learning of the latest developments in the field of rabies, for networking with colleagues from around the world, and for raising the profile of sponsoring agencies on the world stage. As rabies is a zoonotic disease, this conference is an excellent forum for the productive interactions between veterinary and public health professionals promoted by the One World, One Health philosophy.